Intervention

QMF149

ClinicalTrials.gov intervention label

Clinical trials5
Recruiting1
Common conditions3
Lead sponsors shown2

Clinical trials

5 shown
A Study to Evaluate the Efficacy and Safety of QMF149 (Indacaterol Acetate/Mometasone Furoate) Versus Budesonide in Children From 6 to Less Than 12 Years of Age With AsthmaNCT05562466 · 2023-05-11
RECRUITING
Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With AsthmaNCT04589663 · 2021-06-07
COMPLETED
Anti-inflammatory Effects GlycopyrroniumNCT04259164 · 2020-09-10
COMPLETED
A Long-term Safety Study of QMF149 in Japanese Participants With AsthmaNCT03100500 · 2017-04-25
COMPLETED
Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)NCT01636076 · 2012-11-01
COMPLETED

Trial status mix

COMPLETED4
RECRUITING1

Phase mix

PHASE33
PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.